 BioReference Laboratories, Inc., an OPKO Health company NASDAQ:OPK, announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing and molecular diagnostic testing for COVID-19 are available to healthcare providers 